4.6 Editorial Material

'Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs' by Marsh et al

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

Early VEGF testing in inflammatory neuropathy avoids POEMS syndrome misdiagnosis and associated costs

Eleanor S. Marsh et al.

Summary: Misdiagnosis in POEMS syndrome leads to diagnostic delay, disease progression, and significant healthcare costs. Introducing mandatory VEGF testing for patients with acquired demyelinating neuropathy is a cost-effective strategy, allowing for early POEMS diagnosis and timely disease-directed therapy.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2021)

Review Clinical Neurology

Chronic inflammatory demyelinating polyneuropathy: update on diagnosis, immunopathogenesis and treatment

Helmar Christoph Lehmann et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Article Clinical Neurology

Proposal of new clinical diagnostic criteria for POEMS syndrome

Tomoki Suichi et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2019)

Article Clinical Neurology

Different neurological and physiological profiles in POEMS syndrome and chronic inflammatory demyelinating polyneuropathy

Saiko Nasu et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)

Article Clinical Neurology

Uniform demyelination and more severe axonal loss distinguish POEMS syndrome from CIDP

Michelle L. Mauermann et al.

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY (2012)